Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $124.5200 (7.12%) ($114.6100 - $124.5200) on Mon. Jan. 31, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.37% (three month average) | RSI | 27 | Latest Price | $124.5200(7.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.3% a day on average for past five trading days. | Weekly Trend | LGND declines -5.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(62%) IWO(62%) IWM(61%) IWC(57%) IWN(57%) | Factors Impacting LGND price | LGND will decline at least -1.685% in a week (0% probabilities). VIXM(-29%) UUP(-20%) VXX(-17%) UNG(-4%) TBT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.685% (StdDev 3.37%) | Hourly BBV | 2.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $127.14 | 5 Day Moving Average | $116.91(6.51%) | 10 Day Moving Average | $116.42(6.96%) | 20 Day Moving Average | $127.14(-2.06%) | To recent high | -24.9% | To recent low | 10.4% | Market Cap | $2.001b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |